Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 20Pancreatic Fistula 3Gastroparesis 2Bile Duct Neoplasms 2Recurrence 1Pancreatitis, Chronic 1Pancreatic Ductal Adenocarcinoma 1Non-alcoholic Fatty Liver Disease 1Jaundice, Obstructive 1Hypoxia 1Hemorrhage 1Gastrointestinal Stromal Tumor of Duodenum 1Fatty Liver 1Cholangiocarcinoma 1Carcinoma, Pancreatic Ductal 1

Interventions

tislelizumab 1lenvatinib 1Radiomics 1Positron Emission Tomography Computed Tomography 1Pancreaticoduodenectomy 1Electroporation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pancreatic Ductal Adenocarcinoma × Pancreaticoduodenectomy × Clear all
NCT02787187 2021-11-23

Lymphadenectomy for Pancreatic Head Cancer: Standard or Extended?

Ruijin Hospital

Phase NA Completed
230 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡